Patents by Inventor Anker Jon Hansen

Anker Jon Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC ANTIBODIES
    Publication number: 20130295116
    Abstract: The present invention concerns human antibodies recognising the human C5a receptor. By binding to C5aR the antibodies inhibit C5a signalling, whereby the pro-inflammatory signal is inhibited. Based on the role of C5a and its receptor in stimulation of inflammation the invention further relates to therapeutic use of said human anti-C5aR antibodies and in particular in relation to treatment of immunological disorders.
    Type: Application
    Filed: June 18, 2013
    Publication date: November 7, 2013
    Inventors: Stefan Zahn, Louise Hjerrild Zeuthen, Anker Jon Hansen, Kristian Kjaergaard, Soeren Lund
  • Inhibition of the activity of the capsaicin receptor in the treatment of type 1 diabetes, type 2 diabetes, impaired glucose tolerance or insulin resistance
    Patent number: 8455504
    Abstract: The present invention provides a method of treating diseases or disorders benefiting from inactivating or down-regulating the activity of the capsaicin receptor in a mammal by inhibiting the activity of the capsaicin receptor. The present invention also provides a method of treating obesity and obesity-related diseases and disorders in a mammal by inhibiting the activity of the capsaicin receptor.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: June 4, 2013
    Assignee: Xenia Pharma
    Inventors: Dorte Xenia Gram, Anker Jon Hansen
  • THERAPEUTIC ANTIBODIES
    Publication number: 20130004514
    Abstract: The present invention concerns human antibodies recognising the human C5a receptor. By binding to C5aR the antibodies inhibit C5a signalling, whereby the pro-inflammatory signal is inhibited. Based on the role of C5a and its receptor in stimulation of inflammation the invention further relates to therapeutic use of said human anti-C5aR antibodies and in particular in relation to treatment of immunological disorders.
    Type: Application
    Filed: June 6, 2012
    Publication date: January 3, 2013
    Applicant: Novo Nordisk A/S
    Inventors: Stefan Zahn, Louise Hjerrild Zeuthen, Anker Jon Hansen, Kristian Kjaergaard, Soeren Lund
  • Inhibition Of The Activity Of The Capsaicin Receptor In The Treatment Of Obesity Or Obesity-Related Diseases And Disorders
    Publication number: 20110086031
    Abstract: The present invention provides a method of treating diseases or disorders benefiting from inactivating or down-regulating the activity of the capsaicin receptor in a mammal by inhibiting the activity of the capsaicin receptor. The present invention also provides a method of treating obesity and obesity-related diseases and disorders in a mammal by inhibiting the activity of the capsaicin receptor.
    Type: Application
    Filed: December 22, 2010
    Publication date: April 14, 2011
    Inventors: Dorte Xenia Gram, Anker Jon Hansen
  • Inhibition of the activity of the capsaicin receptor in the treatment of obesity or obesity-related diseases and disorders
    Patent number: 7879866
    Abstract: The present invention provides a method of treating diseases or disorders benefiting from inactivating or down regulating the activity of the capsaicin receptor in a mammal by inhibiting the activity of the capsaicin receptor. The present invention also provides a method of treating obesity and obesity-related diseases and disorders in a mammal by inhibiting the activity of the capasaicin receptor.
    Type: Grant
    Filed: July 18, 2005
    Date of Patent: February 1, 2011
    Assignee: Dorte Xenia Gram
    Inventors: Dorte Xenia Gram, Anker Jon Hansen
  • Inhibition of the Activity of the Capsaicin Receptor in the Treatment of Obesity or Obesity-Related Diseases and Disorders
    Publication number: 20080214574
    Abstract: The present invention provides a method of treating diseases or disorders benefiting from inactivating or down regulating the activity of the capsaicin receptor in a mammal by inhibiting the activity of the capasaicin receptor. The present invention also provides a method of treating obesity and obesity-related diseases and disorders in a mammal by inhibiting the activity of the capasaicin receptor.
    Type: Application
    Filed: July 18, 2005
    Publication date: September 4, 2008
    Applicant: Novo Nordisk A/S
    Inventors: Dorte Xenia Gram, Anker Jon Hansen
  • Use of N-substituted azaheterocyclic compounds for the manufacture of a pharmaceutical composition for the treatment of indications related to angiogenesis
    Publication number: 20020045610
    Abstract: The present invention relates to the use of N-substituted azaheterocyclic compounds or salts thereof, for the treatment of conditions related to angiogenesis.
    Type: Application
    Filed: June 1, 2001
    Publication date: April 18, 2002
    Inventors: Anker Jon Hansen, Tine Krogh Jorgensen, Uffe Bang Olsen
  • Treatment of ischemias by administration of 2,N.sup.6 -substituted adenosines
    Patent number: 5683989
    Abstract: The present invention relates to compounds of formula I ##STR1## wherein X is amino, C.sub.1-6 -alkylamino, di-C.sub.1-6 -alkylamino;R.sup.1 is H, straight or branched C.sub.1-6 -alkyl or trifluoromethyl; R.sup.4 is H or straight or branched C.sub.1-6 -alkyl; or R.sup.1 and R.sup.4 together form a cyclobutyl, cyclopentyl or cyclohexyl ring;Y is O, S, SO.sub.2, N--H or N-alkyl;R.sup.5 is selected from optionally substituted heterocycles;R.sup.6 is hydrogen, benzoyl or C.sub.1-6 -alkanoyl andR.sup.7 is hydrogen, benzoyl or C.sub.1-6 -alkanoyl; ora pharmaceutically acceptable salt thereof.The compounds have been found useful for treating central nervous system and cardiovascular ailments.
    Type: Grant
    Filed: July 20, 1995
    Date of Patent: November 4, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Jesper Lau, Lars Jacob Stray Knutsen, Malcolm Sheardown, Anker Jon Hansen